 immunohistochem studi androgen receptor metastat prostat cancer comparison receptor content respons hormon therapi longstand goal androgen receptor AR level clinic respons metastat prostat cancer withdraw therapi major limit previou studi use homogen tissu averag AR content cell AR immunohistochem studi antibodi specif AR author nuclear AR content malign epitheli cell prostat needl biopsi specimen patient stage prostat cancer author prostat cancer ar-posit ar-neg malign cell androgen withdraw therapi percentag ar-posit cell time progress therapi signific correl percentag ar-posit malign cell time progress patient group median time progress percentag ar-posit nuclei differ poor respond good respond patient group median percentag receptor-posit nuclei kaplan-mei estim progression-fre interv signific differ group patient ar-poor tumor patient ar-rich tumor potenti explan result author percentag ar-posit nuclei suffici criterion tumor behavior